» Articles » PMID: 23871813

Endoscopic-assisted Visualization of 5-aminolevulinic Acid-induced Fluorescence in Malignant Glioma Surgery: a Technical Note

Overview
Journal World Neurosurg
Publisher Elsevier
Date 2013 Jul 23
PMID 23871813
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: With the use of fluorescence-guided resection with 5-aminolevulinic acid (5-ALA), the rate of complete resection of the contrast-enhancing part of malignant gliomas could be increased from 36% to 65%. Because the visualization of 5-ALA-induced fluorescence depends on a sufficient exposure to fluorescent light, residual tumor tissue in deep-seated resection cavities might not be detected. In addition, subcortical parts of a large spherical tumor might not be visualized, owing to a tangential position at the periphery of the microscopic field. With the availability of a specially designed endoscope with the capability to visualize 5-ALA fluorescence, we investigated the impact of this new technique on the visualization of residual glioma tissue.

Methods: A standard dose of 5-ALA 20 mg/kg was administered to 9 patients with deep-seated contrast-enhancing brain tumors 3 hours before surgery. A standard surgical exposure was performed and supplemented by the use of a specially designed endoscope with an option of 5-ALA fluorescence guidance. After microscopic visualization of the surgical cavity, endoscopic visualization was employed. If additional fluorescence tissue was detected, microscopic visualization was performed. Detected remnants of the tumor were removed and evaluated by histologic examination.

Results: In all cases, fluorescence-guided endoscopic visualization identified 5-ALA-positive tissue not sufficiently exposed by conventional microscopic visualization. In 8 patients, histopathologic examination confirmed residual tumor tissue; in 1 patient, the endoscopic visualized tissue was classified as radiation necrosis. In this patient, the tumor was completely ALA negative microscopically.

Conclusions: As an additional instrument, fluorescence-guided endoscopic visualization might help to overcome technical limitations of the conventional microscopic exposure of 5-ALA-positive tumor tissue. The false-positive 5-ALA tissue indicates that endoscopic visualization may overestimate the amount of tumor, so further analyses to ascertain the sensitivity and specificity of this technique are required.

Citing Articles

Second-Generation Wide-Field Visualization Devices for 5-ALA-Induced Fluorescence and Concepts for Validation in Neurosurgery-A Systematic Review.

Ozdemir Z, Suero Molina E, Hellwig S, Stepp H, Stummer W Neurosurg Pract. 2025; 4(4):e00059.

PMID: 39959385 PMC: 11809958. DOI: 10.1227/neuprac.0000000000000059.


Advancement of fluorescent aminopeptidase probes for rapid cancer detection-current uses and neurosurgical applications.

Shimizu T, Tanaka S, Kitagawa Y, Sakaguchi Y, Kamiya M, Takayanagi S Front Surg. 2024; 11:1298709.

PMID: 38516394 PMC: 10954885. DOI: 10.3389/fsurg.2024.1298709.


5-aminolevulinic acid-guided endoscopic biopsy with violet light-emitting diode flashlight in malignant glioma: Technical note.

Yoshida M, Yamaguchi S, Iwasaki K, Iwanaga M Surg Neurol Int. 2023; 14:397.

PMID: 38053712 PMC: 10695459. DOI: 10.25259/SNI_204_2023.


Endoscope-enhanced fluorescence-guided microsurgery increases survival in patients with glioblastoma.

Bettag C, Schatlo B, Abboud T, Behme D, Bock C, von der Brelie C Acta Neurochir (Wien). 2023; 165(12):4221-4226.

PMID: 37950066 PMC: 10739506. DOI: 10.1007/s00701-023-05862-6.


5-Aminolevulinic acid fluorescence-guided endoscopic surgery for intraventricular tumors.

Takeda J, Nonaka M, Li Y, Isozaki H, Kamei T, Hashiba T Surg Neurol Int. 2022; 13:302.

PMID: 35928327 PMC: 9345107. DOI: 10.25259/SNI_488_2022.